Cicletanine

DRUG2 trials

Sponsors

Gilead Sciences, Navitas Pharma

Conditions

Arterial HypertensionDiabetesHypokalemiaHyponatremiaPulmonary Arterial Hypertension

Phase 1

Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium

Navitas PharmaArterial Hypertension, Diabetes, Hypokalemia +1

Start: 2022-06-30End: 2024-09-30Target: 24Updated: 2021-09-05

Phase 2

Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)

TerminatedNCT00832507

Gilead SciencesPulmonary Arterial Hypertension

Start: 2009-01-31End: 2012-03-31Updated: 2014-02-04